| Post | Subject | Posted By | Time |
|
#39
|
Ardea Biosciences Reports Recent Accomplishments and Announces Third
|
surf1944
| 11/6/2009 8:29:18 AM |
|
#38
|
Ardea Biosciences Announces Additional Positive Results from a
|
surf1944
| 10/19/2009 8:18:32 AM |
|
#36
|
Ardea Biosciences to Present Results from a Phase
|
surf1944
| 9/30/2009 8:59:20 AM |
|
#35
|
Distribution taking place in RDEA, took a short
|
surf1944
| 9/25/2009 11:41:08 AM |
|
#34
|
Ardea Beats Zacks Estimate
|
surf1944
| 8/11/2009 3:05:30 PM |
|
#33
|
On 7/20/09, Ardea Biosciences (RDEA) announced that it
|
surf1944
| 7/29/2009 9:01:03 AM |
|
#32
|
Ardea Biosciences Initiates Phase 2b Clinical Trial of
|
surf1944
| 7/29/2009 9:00:11 AM |
|
#31
|
Ardea Bio Results Promising
|
surf1944
| 6/24/2009 3:22:18 PM |
|
#30
|
Ardea lead drug performing well in midstage study
|
surf1944
| 6/12/2009 1:35:19 PM |
|
#29
|
Ardea Biosciences to Present Preclinical and Phase 1
|
surf1944
| 5/18/2009 9:00:48 AM |
|
#28
|
Ardea Biosciences and Bayer HealthCare Enter into Global
|
surf1944
| 4/28/2009 8:39:25 AM |
|
#27
|
13-Mar-09 JMP Securities Initiated RDEA
|
surf1944
| 3/20/2009 9:06:25 AM |
|
#26
|
http://www.mffais.com/rdea.html
|
surf1944
| 3/20/2009 9:05:19 AM |
|
#25
|
http://www.form4oracle.com/company?cik=0001103390&ticker=RDEA
|
surf1944
| 3/20/2009 9:04:58 AM |
|
#24
|
Ardea Biosciences to Present Preclinical Multi-Drug Combination Synergy
|
surf1944
| 3/20/2009 9:04:27 AM |
|
#23
|
Ardea Biosciences to Present Data on Gout and
|
surf1944
| 9/16/2008 9:49:52 AM |
|
#22
|
Ardea Biosciences to Present Data on Lead MEK
|
surf1944
| 9/11/2008 8:37:13 AM |
|
#21
|
Ardea Biosciences Advances Lead Product Candidate for the
|
surf1944
| 8/21/2008 8:24:34 AM |
|
#20
|
Ardea Biosciences Still Developing
|
surf1944
| 8/18/2008 11:42:14 AM |
|
#19
|
Ardea Biosciences Presents Phase 2a Antiviral Activity Data
|
surf1944
| 8/8/2008 1:32:40 PM |
|
#18
|
Ardea to Present Data on Lead HIV Candidate,
|
surf1944
| 7/17/2008 9:48:53 AM |
|
#17
|
Ardea Biosciences Reports Additional Positive Phase 2a Results
|
surf1944
| 6/25/2008 8:29:20 AM |
|
#16
|
Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating
|
surf1944
| 5/20/2008 9:04:13 PM |
|
#15
|
Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
|
surf1944
| 5/19/2008 9:01:39 AM |
|
#14
|
Ardea Biosciences to Present Data on Lead MEK
|
surf1944
| 5/15/2008 7:51:57 AM |
|
#13
|
Ardea Biosciences Appoints John W. Beck Chief Financial
|
surf1944
| 5/9/2008 8:34:35 AM |
|
#12
|
Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and
|
surf1944
| 4/15/2008 4:33:17 PM |
|
#11
|
Ardea Presents Preclinical Data on Novel Next Generation
|
surf1944
| 4/14/2008 8:58:23 AM |
|
#10
|
Ardea to Present Data on HIV Non-Nucleoside Reverse
|
surf1944
| 4/7/2008 8:54:57 AM |
|
#9
|
Ardea Biosciences Reports Progress of Clinical Development Programs;
|
surf1944
| 3/24/2008 8:45:03 AM |
|
#8
|
Ardea HIV Drug Meeting Study Goals
|
surf1944
| 3/18/2008 6:55:09 AM |
|
#7
|
30-Jan-08
Cowen & Co Initiated
|
surf1944
| 1/30/2008 9:38:04 AM |
|
#6
|
Insider and fund buying over the past month
|
surf1944
| 1/9/2008 2:00:15 PM |
|
#5
|
Ardea Biosciences' Lead NNRTI for HIV, RDEA806, to
|
surf1944
| 1/2/2008 8:42:54 AM |
|
#4
|
Ardea Biosciences, Inc. Announces New Clinical Development Program
|
surf1944
| 11/28/2007 9:08:25 AM |
|
#3
|
Ardea Biosciences, Inc. Reports Third Quarter 2007 Operating
|
surf1944
| 11/14/2007 5:07:24 PM |
|
#2
|
New Oral MEK Inhibitor, RDEA119, Shows Favorable Anti-Tumor Properties
|
surf1944
| 10/24/2007 3:41:11 PM |
|
#1
|
Ardea Biosciences to List on the NASDAQ Capital Market
|
surf1944
| 10/24/2007 9:45:00 AM |